International Journal of Biological MacromoleculesMicrobiologyPeer-reviewed journal article
Coronavirus Nucleocapsid Proteins Hijack Host Protein Kinase A Catalytic Subunit α into Nucleus to Evade from STAT1 Signaling
Jidong Xu, Yuting XiaoiD, Wanqing Lu, Ziyao Song, Lei Zhou, Qin Gao, X XuiD, Ying ShaniD, Weihuan FangiD, Lingyan Zhao, Xiaoliang Li
Abstract
The role of the cAMP/PKA pathway in antiviral innate immunity, including during coronavirus infections, remains unclear. We discovered coronavirus N proteins initiate cAMP-ADCY10-PKA cascade. Cytoplasmic PKA activates STAT1 independently of canonical JAK/TYR2 signaling. Coronavirus N proteins, via a conserved arginine (e.g., PEDV R58, SARS-CoV-2 R92), directly bind and sequester PKA C into the nucleus to evade STAT1 activation. Using PEDV as a model, mutant viruses with NmutNLS and NR58A were generated. Wildtype PEDV infection suppressed STAT1 activation in cells expressing PKA C/PKA CS339A deficient in STAT1 phosphorylation. However, in rXS0101mutNLS- or rXS0101R58A-infected cells, only PKA CS339A expression inhibited STAT1 activation. Downregulation of STAT1 activation is accompanied with increased viral replication. This study first elaborates that PKA C activates STAT1 in the cytoplasm of infected cells distinctly from canonical JAK/STAT1 signaling, while coronaviruses evade this antiviral response by sequestering PKA C into the nucleus via direct N protein interaction.
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 21th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Coronavirus Nucleocapsid Protein Enhances the binding of p-PKCα to RACK1: Implications for Inhibition of Nucleocytoplasmic Trafficking and Suppression of the Innate Immune Response
Y. Liao, W. Xue, … C. Ding·PLOS PathogensPeer-reviewed·Nov 27, 2024
- SARS-CoV-2 hijacks p38β/MAPK11 to promote viral protein translation
C. A. Higgins, B. E. Nilsson-Payant, … J. R. Johnson·bioRxiv·Aug 20, 2021
- Proof-of-concept of targeted degradation of p38α/β MAPK host-kinase as a potent inhibitor of coronaviruses.
Gemma Cooper, Timothy J. Snape, Maitreyi Shivkumar·bioRxiv·Apr 30, 2026
- Human coronavirus nucleocapsid proteins have disparate innate immune evasion abilities
Noga Sharlin, Rory P. Mulloy, … Jennifer A. Corcoran·bioRxiv·Jul 16, 2026
- The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
T. M. Yaron, B. E. Heaton, … M Kavanagh-Williamson·bioRxiv·Aug 14, 2020
- Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for therapy